The paper follows 107 patients from seven centers in the United States with a 3.7 average follow-up after minimally invasive SI joint fusion. The researchers found:
1. Average SI joint pain at baseline was 7.5, but at the 3.7 year follow-up the SI joint pain score showed a 4.8-point improvement to 2.6.
2. The average ODI score at follow-up was 28.2, similar to the two-year prospective clinical trial outcomes for SI joint fusion.
3. Only five patients reported revision surgery, identical to the results from the two-year study.
4. There are now 40 peer-reviewed publications supporting the positive clinical outcomes for minimally invasive SI joint fusion, two of which are randomized controlled trials. The device has FDA clearance.
5. The minimally invasive SI joint fusion is covered by several Medicare contractors across the United States.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
